IBRX: ImmunityBio Inc - Common Stock

2.56 USD 0.02 (0.78%)

Sektor: Gesundheitswesen Basis: US Dollar Gewinnwährung: US Dollar

Der Wechselkurs von IBRX hat sich für heute um -0.78% verändert. Im Laufe des Tages wurde das Instrument von einem Tief von 2.54 bis zu einem Hoch von 2.67 gehandelt.

Verfolgen Sie die ImmunityBio Inc - Common Stock-Dynamik. Mit Echtzeit-Kursen können Sie schnell auf Marktveränderungen reagieren. Indem Sie zwischen verschiedenen Zeitrahmen wechseln, können Sie Kurstrends und -dynamik nach Minuten, Stunden, Tagen, Wochen und Monaten verfolgen. Nutzen Sie diese Informationen, um Marktveränderungen vorherzusagen und fundierte Handelsentscheidungen zu treffen.

Vollbild-Chart

IBRX News

Investing 16:34 Trump administration prepares emergency declaration for Brazil tariffs - Bloomberg
Benzinga 06:36 LA Times Going Public? Patrick Soon-Shiong Plans Green Bay-Style Ownership To 'Democratize' 143-Year-Old Paper - ImmunityBio (NASDAQ:IBRX)
Investing 05:30 Los Angeles Times to go public, owner Soon-Shiong says
Seeking Alpha 14:45 ImmunityBio Stock: Still Flashing Signs Life After Another ANKTIVA Approval (NASDAQ:IBRX)
Seeking Alpha 10:51 ImmunityBio: High Stakes On ANKTIVA's Growth Amidst FDA Friction And Financial Pressures
Seeking Alpha 13:09 ImmunityBio: Lymphopenia Opportunity Could Provoke Short Squeeze (NASDAQ:IBRX)
Investing 18:05 Alibaba, Tesla Lead Market Cap Stock Movers on Wednesday
Investing 11:37 H.C. Wainwright maintains buy rating on ImmunityBio stock after FDA milestones
Investing 13:04 ASCO Report of Pioneering Treatment of Lymphopenia with Significant Overall Survival Benefit in Advanced Pancreatic Cancer
Investing 14:31 Nvidia, Veeva Surge Among Thursday’s Market Cap Stock Movers
Investing 12:32 ImmunityBio, Saudi Arabia’s Ministry of Investment, KFSHRC, and KAIMRC Sign Strategic Memorandum of Understanding to Launch Cancer BioShield™ Platform in the Middle East
Investing 14:31 Amer Sports, Viking Holdings lead Tuesday’s market cap stock movers
Investing 11:30 Piper Sandler raises ImmunityBio stock rating, target to $5
Benzinga 17:11 Foot Locker And Archer Aviation Are Among Top 8 Mid-Cap Gainers Last Week (May 12-May 16): Are The Others In Your Portfolio? - Archer Aviation (NYSE:ACHR), Foot Locker (NYSE:FL)
Benzinga 13:21 ImmunityBio Slapped With FDA Refusal To File Letter For Expanded Use Of Its Bladder Cancer Drug - ImmunityBio (NASDAQ:IBRX)
Benzinga 12:18 Netflix, CNA Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Guardant Health (NASDAQ:GH), CNA Financial (NYSE:CNA)
Investing 11:59 ImmunityBio stock sinks after FDA issues RTF letter
Seeking Alpha 21:54 ImmunityBio: Taking Care Of Business (NASDAQ:IBRX)
Benzinga 14:15 Concentrix Posts Better-Than-Expected Earnings, Joins Soleno Therapeutics, Petco Health and Wellness, MillerKnoll And Other Big Stocks Moving Higher On Thursday - Avis Budget Gr (NASDAQ:CAR), Concentrix (NASDAQ:CNXC)
Seeking Alpha 06:47 ImmunityBio: BCG Shortage And Tariff Risks May Stifle Anktiva’s Commercial Momentum (IBRX)
Benzinga 18:09 ImmunityBio Analyst Predicts Strong 2025 For New Bladder Cancer Drug - ImmunityBio (NASDAQ:IBRX)
Benzinga 14:33 This Tourmaline Bio Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday - ImmunityBio (NASDAQ:IBRX), Aduro Clean Technologies (NASDAQ:ADUR)
Investing 21:32 ImmunityBio stock rises on Q4 earnings beat, revenue growth
Benzinga 17:18 Tesla Rebounds While Tariffs Weigh On Manufacturing: What's Driving Markets Monday? - SPDR S&P 500 (ARCA:SPY)

Tagesspanne

2.54 2.67

Jahresspanne

1.83 7.49

Vorheriger Schlusskurs: 2.54
Eröffnung: 2.58

Bid: 2.56
Ask: 2.86

Tief: 2.54
Hoch: 2.67

Volumen: 4.313 K

Tagesänderung: -0.78%
Monatsänderung: -1.54%

6-Monatsänderung: -21.71%
Jahresänderung: -50.29%

31 Juli, Donnerstag